Guidance regarding COVID‐19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group

Verbruggen, Lisanne C.; Wang, Yuehan; Armenian, Saro H.; Ehrhardt, Matthew J.; van der Pal, Helena J.H.; van Dalen, Elvira C.; van As, Jorrit W.; Bardi, Edit; Baust, Katja; Berger, Claire; Castagnola, Elio; Devine, Katie A.; Gebauer, Judith; Marchak, Jordan Gilleland; Glaser, Adam W.; Groll, Andreas H.; Haeusler, Gabrielle M.; den Hartogh, Jaap; Haupt, Riccardo; Hjorth, Lars; Kato, Miho; Kepák, Tomáš; Koopman, Maria M.W. (Rianne); Langer, Thorsten; Maeda, Miho; Michel, Gisela; Muraca, Monica; Nathan, Paul C.; van den Oever, Selina R.; Pavasovic, Vesna; Sato, Satomi; Schulte, Fiona; Sung, Lillian; Tissing, Wim; Uyttebroeck, Anne; Mulder, Renée L.; Kuehni, Claudia; Skinner, Roderick; Hudson, Melissa M.; Kremer, Leontien C.M.

Childhood, adolescent, and young adult (CAYA) cancer survivors may be at risk for a severe course of COVID‐19. Little is known about the clinical course of COVID‐19 in CAYA cancer survivors, or if additional preventive measures are warranted. We established a working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) to summarize existing evidence and worldwide recommendations regarding evidence about factors/conditions associated with risk for a severe course of COVID‐19 in CAYA cancer survivors, and to develop a consensus statement to provide guidance for healthcare practitioners and CAYA cancer survivors regarding COVID‐19.